Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 13, 2021 - Issue
Submit an article Journal homepage
274
Views
5
CrossRef citations to date
0
Altmetric
Original Research

MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients

Ibnu Purwanto1 Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, IndonesiaCorrespondence[email protected]
,
Didik Setyo Heriyanto2 Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, Indonesia
,
Irianiwati Widodo2 Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, Indonesia
,
Mohammad Hakimi3 Department of Clinical Epidemiology and Biostatistics Unit, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, Indonesia
,
Mardiah Suci Hardianti1 Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, Indonesia
,
Teguh Aryandono4 Department of Surgical Oncology, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, Indonesia
&
Sofia Mubarika Haryana5 Department of Histology and Cell Biology, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta, Indonesia
 show all
Pages 1-7 | Published online: 06 Jan 2021

References

  • LiedtkeC, MazouniC, HessKR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275–1281. doi:10.1200/JCO.2007.14.414718250347
  • GaoY, LinL, LiT, et al. The role of miRNA-223 in cancer: function, diagnosis and therapy. Gene. 2017;616:1–7.28322994
  • ZhouX, JinW, JiaH, et al. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7. J Exp Clin Cancer Res. 2015;34(1):28. doi:10.1186/s13046-015-0145-625888377
  • DingJ, ZhaoZ, SongJ, et al. MiR-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting FBXW7. Acta Biochim Biophys Sin. 2018;50(6):597–604. doi:10.1093/abbs/gmy04029701752
  • SunX, LiY, ZhengM, et al. MicroRNA-223 increases the sensitivity of triple-negative breast cancer stem cells to trail-induced apoptosis by targeting HAX-1. PLoS One. 2016;11(9):e0162754. doi:10.1371/journal.pone.016275427618431
  • SahlbergKK, BottaiG, NaumeB, et al. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Clin Cancer Res. 2015;21(5):1207–1214. doi:10.1158/1078-0432.CCR-14-201125547678
  • YoshikawaM, IinumaH, UmemotoY, et al. Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer. Oncol Lett. 2018;15(6):9584–9592.29805680
  • CitronF, SegattoI, VinciguerraGL, et al. Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to cdk4/6 inhibitors in luminal breast cancer. Cancer Res. 2020;80(5):1064–1077. doi:10.1158/0008-5472.CAN-19-179331862778
  • MaedaT, NakanishiY, HirotaniY, et al. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer. Med Mol Morphol. 2016;49:1:11–21. doi:10.1007/s00795-015-0109-0
  • ChangaviAA, ShashikalaA, RamjiAS. Epidermal growth factor receptor expression in triple negative and nontriple negative breast carcinomas. J Lab Physicians. 2015;7(2):79–83. doi:10.4103/0974-2727.16312926417156
  • StaudacherL, CottuPH, DiérasV, et al. Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience. Ann Oncol. 2011;22(4):848–856. doi:10.1093/annonc/mdq46120924076
  • KoshyN, QuispeD, ShiR, et al. Cisplatin-gemcitabine therapy in metastatic breast cancer: improved outcome in triple negative breast cancer patients compared to non-triple negative patients. Breast. 2010;19(3):246–248. doi:10.1016/j.breast.2010.02.00320227277
  • FoulkesWD, SmithIE, Reis-FilhoJS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938–1948. doi:10.1056/NEJMra100138921067385
  • BelliC, DusoBA, FerraroE, CuriglianoG. Homologous recombination deficiency in triple negative breast cancer. Breast. 2019;45:15–21. doi:10.1016/j.breast.2019.02.00730818144
  • TaninoH, KosakaY, NishimiyaH, et al. BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy. PLoS One. 2016;11(12):e0165721. doi:10.1371/journal.pone.016572127935989
  • OonkAMM, van RijnC, SmitsMM, et al. Clinical correlates of ‘BRCAness’ in triple-negative breast cancer of patients receiving adjuvant chemotherapy. Ann Oncol. 2012;23(9):2301–2305. doi:10.1093/annonc/mdr62122357256
  • HillDP, HarperA, MalcolmJ, et al. Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance. BMC Cancer. 2019;19(1):1039. doi:10.1186/s12885-019-6278-931684899
  • NedeljkovićM, DamjanovićA. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge. Cells. 2019;8(9):957. doi:10.3390/cells8090957
  • WangH, ChenJ, ZhangS, et al. MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer. Cancer Cell Int. 2020;20:258. doi:10.1186/s12935-020-01284-x32577098

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.